Abstract:In order to treat degenerative diseases, the importance of advanced therapy medicinal products has increased in recent years. The newly developed treatment strategies require a rethinking of the appropriate analytical methods. Current standards are missing the complete and sterile analysis of the product of interest to make the drug manufacturing effort worthwhile. They only consider partial areas of the sample or product while also irreversibly damaging the investigated specimen. Two-dimensional T1 / T2 MR relaxometry meets these requirements and is therefore a promising in-process control during the manufacturing and classification process of cell-based treatments. In this study a tabletop MR scanner was used to perform two-dimensional MR relaxometry. Throughput was increased by developing an automation platform based on a low-cost robotic arm, resulting in the acquisition of a large dataset of cell-based measurements. Two-dimensional inverse Laplace transformation was used for post-processing, followed by data classification performed with support vector machines (SVM) as well as optimized artificial neural networks (ANN). The trained networks were able to distinguish non-differentiated from differentiated MSCs with a prediction accuracy of 85%. To increase versatility, an ANN was trained on 354 independent, biological replicates distributed across ten different cell lines, resulting in a prediction accuracy of up to 98% depending on data composition. The present study provides a proof of principle for the application of T1 / T2 relaxometry as a non-destructive cell classification method. It does not require labeling of cells and can perform whole mount analysis of each sample. Since all measurements can be performed under sterile conditions, it can be used as an in-process control for cellular differentiation. This distinguishes it from other characterization techniques, as most are destructive or require some type of cell labeling. These advantages highlight the technique's potential for preclinical screening of patient-specific cell-based transplants and drugs.

Rapid identification of differentiation markers from whole epithelial cells by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry and statistical analysis

[Use of Laser Capture Microdissection and Surface-Enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Differential Proteins in Lung Adenocarcinoma and Lung Squamous Carcinoma].

Ratiometric Mass Spectrometry for Cell Identification and Quantitation Using Intracellular "Dual-Biomarkers".

Intracellular Surface-Enhanced Raman Scattering Probes Based on TAT Peptide-Conjugated Au Nanostars for Distinguishing the Differentiation of Lung Resident Mesenchymal Stem Cells.

Determination of Tenogenic Differentiation in Human Mesenchymal Stem Cells by Terahertz Waves for Measurement of the Optical Property of Cellular Suspensions

Adipose-derived mesenchymal stem cells' adipogenesis chemistry analyzed by FTIR and Raman metrics

Identification of Differential Expressed Proteins Between High and Low Differentiation Cancers of Larynx Tissues by Two-Dimensional Electrophoresis and MALDI-TOF Mass Spectrometry

Monitoring human mesenchymal stromal cell differentiation by electrochemical impedance sensing.

Determining the stages of cellular differentiation using Deep Ultraviolet Resonance Raman Spectroscopy

Identification of differential expressed proteins between high and low differentiation colorectal carcinoma tissues by two-dimensional electrophoresis and MALDI-TOF mass spectrometry

Development of Visible-Wavelength MALDI Cell Mass Spectrometry for High-Efficiency Single-Cell Analysis.

Selected protein monitoring in histological sections by targeted MALDI-FTICR in-source decay imaging

Whole-cell matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for rapid identification of bacteria cultured in liquid media

Lipidomic Typing of Colorectal Cancer Tissue Containing Tumour-Infiltrating Lymphocytes by MALDI Mass Spectrometry Imaging

Aluminium Foil As a Single-Use Substrate for MALDI-MS Fingerprinting of Different Melanoma Cell Lines.

Investigation of the Lipidomic Changes in Differentiated Glioblastoma Cells after Drug Treatment Using MALDI-MS.

Differentiation of MCF-7 tumor cells from leukocytes and fibroblast cells using epithelial cell adhesion molecule targeted multicore surface-enhanced Raman spectroscopy labels

MALDI Profiling MS Application to Analysis of Non-small Cell Lung Cancer

Non-destructive classification of unlabeled cells: Combining an automated benchtop magnetic resonance scanner and artificial intelligence

Looking at time dependent differentiation of mesenchymal stem cells by culture media using MALDI-TOF-MS

Application of selected reaction monitoring and parallel reaction monitoring for investigation of HL-60 cell line differentiation